ARTIOS Phase IIIb, open-label, single-arm, prospective study showed a substantial reduction in disease activity in people with relapsing multiple sclerosis (RMS)following switch to Kesimpta after ...
Charles Okah, who is serving a life sentence at the Maximum Security Custodial Centre in Maiduguri for the 2010 Independence ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results